두경부암의 지방산 대사 표적화

키워드

참고문헌 (67)

1. Hanahan D, "The hallmarks of cancer", Cell, 100(1), pp.57~70 (2000)
2. Hanahan D, "Hallmarks of cancer : The next generation", Cell, 144(5), pp.646~674 (2011)
3. Vander Heiden MG, "Understanding the Warburg effect : The metabolic requirements of cell proliferation", Science, 324(5930), pp.1029~1033 (2009)
4. Warburg O, "The metabolism of tumors in the body", J Gen Physiol, 8(6), pp.519~530 (1927)
5. Weinhouse S, "Studies on the fate of isotopically labeled metabolites in the oxidative metabolism of tumors", Cancer Res, 11(8), pp.585~591 (1951)
6. Weinhouse S, "Oxidative metabolism of neoplastic tissues", Adv Cancer Res, 3, pp.269~325 (1955)
7. Fantin VR, "Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance", Cancer Cell, 9(6), pp.425~434 (2006)
8. Moreno-Sánchez R, "Energy metabolism in tumor cells", FEBS J, 274(6), pp.1393~1418 (2007)
9. DeBerardinis RJ, "The biology of cancer : Metabolic reprogramming fuels cell growth and proliferation", Cell Metab, 7(1), pp.11~20 (2008)
10. Hay N, "Reprogramming glucose metabolism in cancer : Can it be exploited for cancer therapy", Nat Rev Cancer, 16(10), pp.635~649 (2016)
11. Sonveaux P, "Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice", J Clin Invest, 118(12), pp.3930~3942 (2008)
12. Stine ZE, "MYC, metabolism, and cancer", Cancer Discov, 5(10), pp.1024~1039 (2015)
13. Pascual G, "Targeting metastasis-initiating cells through the fatty acid receptor CD36", Nature, 541(7635), pp.41~45 (2017)
14. Watt MJ, "Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer", Sci Transl Med, 11(478), pp.eaau5758~ (2019)
15. Nieman KM, "Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth", Nat Med, 17(11), pp.1498~1503 (2011)
16. Balaban S, "Adipocyte lipolysis links obesity to breast cancer growth : Adipocyte-derived fatty acids drive breast cancer cell proliferation and migration", Cancer Metab, 5, pp.1~ (2017)
17. Currie E, "Cellular fatty acid metabolism and cancer", Cell Metab, 18(2), pp.153~161 (2013)
18. Seo J, "Metastasis-on-a-chip reveals adipocyte-derived lipids trigger cancer cell migration via HIF-1α activation in cancer cells", Biomaterials, 269, pp.120622~ (2021)
19. Mitsuishi Y, "Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming", Cancer Cell, 22(1), pp.66~79 (2012)
20. Berwick DC, "The identification of ATP-citrate lyase as a protein kinase B(Akt)substrate in primary adipocytes", J Biol Chem, 277(37), pp.33895~33900 (2002)
21. Liu Y, "Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer", Prostate Cancer Prostatic Dis, 9(3), pp.230~234 (2006)
22. Holder AM, "High stearoyl-CoA desaturase 1expression is associated with shorter survival in breast cancer patients", Breast Cancer Res Treat, 137(1), pp.319~327 (2013)
23. Huang J, "SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma", Oncotarget, 7(26), pp.39970~39979 (2016)
24. Ackerman D, "Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation", Cell Rep, 24(10), pp.2596~2605 (2018)
25. Kamphorst JJ, "Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids", Proc Natl Acad Sci U S A, 110(22), pp.8882~8887 (2013)
26. Rysman E, "De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation", Cancer Res, 70(20), pp.8117~8126 (2010)
27. Zalba S, "Cell membrane modulation as adjuvant in cancer therapy", Cancer Treat Rev, 52, pp.48~57 (2017)
28. Lee CK, "Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation", Science, 363(6427), pp.644~649 (2019)
29. Jeon SM, "AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress", Nature, 485(7400), pp.661~665 (2012)
30. Zhang M, "Adipocyte-derived lipids mediate melanoma progression via FATP proteins", Cancer Discov, 8(8), pp.1006~1025 (2018)
31. Carvalho MA, "Fatty acid synthase inhibition with orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model", Int J Cancer, 123(11), pp.2557~2565 (2008)
32. Loftus TM, "Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors", Science, 288(5475), pp.2379~2381 (2000)
33. Zadra G, "Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer", Proc Natl Acad Sci U S A, 116(2), pp.631~640 (2019)
34. Wang X, "Green tea epigallocatechin gallate : A natural inhibitor of fatty-acid synthase", Biochem Biophys Res Commun, 288(5), pp.1200~1206 (2001)
35. Lupu R, "Pharmacological inhibitors of fatty acid synthase (FASN)--catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?", Curr Pharm Biotechnol, 7(6), pp.483~493 (2006)
36. Knobloch M, "Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis", Nature, 493(7431), pp.226~230 (2013)
37. Jiang L, "Metabolic reprogramming during TGFβ1-induced epithelial-tomesenchymal transition", Oncogene, 34(30), pp.3908~3916 (2015)
38. Thupari JN, "C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity", Proc Natl Acad Sci U S A, 99(14), pp.9498~9502 (2002)
39. Zaytseva YY, "Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer", Oncotarget, 9(37), pp.24787~24800 (2018)
40. Menendez JA, "Fatty acid synthase(FASN)as a therapeutic target in breast cancer", Expert Opin Ther Targets, 21(11), pp.1001~1016 (2017)
41. Migita T, "ATP citrate lyase : Activation and therapeutic implications in non-small cell lung cancer", Cancer Res, 68(20), pp.8547~8554 (2008)
42. Hatzivassiliou G, "ATP citrate lyase inhibition can suppress tumor cell growth", Cancer Cell, 8(4), pp.311~321 (2005)
43. Beckers A, "Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells", Cancer Res, 67(17), pp.8180~8187 (2007)
44. Wang C, "Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis", Biochem Biophys Res Commun, 385(3), pp.302~306 (2009)
45. Luo J, "AcetylCoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab", Cancer Lett, 384, pp.39~49 (2017)
46. Yang J, "Targeting cellular metabolism to reduce head and neck cancer growth", Sci Rep, 9(1), pp.4995~ (2019)
47. Li X, "Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling", Mol Cancer Ther, 13(4), pp.855~866 (2014)
48. Chen M, "An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer", Nat Genet, 50(2), pp.206~218 (2018)
49. Tang JJ, "Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques", Cell Metab, 13(1), pp.44~56 (2011)
50. Chen W, "Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice", Cell Metab, 5(1), pp.73~79 (2007)
51. Flaveny CA, "Broad anti-tumor activity of a small molecule that selectively targets the warburg effect and lipogenesis", Cancer Cell, 28(1), pp.42~56 (2015)
52. Marien E, "Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma", Oncotarget, 7(11), pp.12582~12597 (2016)
53. Peck B, "Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments", Cancer Metab, 4, pp.6~ (2016)
54. Mason P, "SCD1 inhibition causes cancer cell death by depleting monounsaturated fatty acids", PLoS One, 7(3), pp.e33823~ (2012)
55. Potze L, "Betulinic acid kills colon cancer stem cells", Curr Stem Cell Res Ther, 11(5), pp.427~433 (2016)
56. Ma MKF, "Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation", J Hepatol, 67(5), pp.979~990 (2017)
57. Pisanu ME, "Blockade of stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells", Cancer Lett, 406, pp.93~104 (2017)
58. Vriens K, "Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity", Nature, 566(7744), pp.403~406 (2019)
59. Luo J, "An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism", Tumour Biol, 37, pp.15795~15804 (2016)
60. Liu PP, "Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline", Oncogene, 35(43), pp.5663~5673 (2016)
61. Kantor PF, "The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase", Circ Res, 86(5), pp.580~588 (2000)
62. Nash DT, "Ranolazine for chronic stable angina", Lancet, 372(9646), pp.1335~1341 (2008)
63. Pollak MN, "Investigating metformin for cancer prevention and treatment : The end of the beginning", Cancer Discov, 2(9), pp.778~790 (2012)
64. Sadowski MC, "The fatty acid synthase inhibitor triclosan : Repurposing an anti-microbial agent for targeting prostate cancer", Oncotarget, 5(19), pp.9362~9381 (2014)
65. Fritz V, "Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice", Mol Cancer Ther, 9(6), pp.1740~1754 (2010)
66. Carracedo A, "Cancer metabolism : Fatty acid oxidation in the limelight", Nat Rev Cancer, 13(4), pp.227~232 (2013)
67. Shackelford DB, "LKB1 inactivation dictates therapeutic response of nonsmall cell lung cancer to the metabolism drug phenformin", Cancer Cell, 23(2), pp.143~158 (2013)

관련 논문AI추천